November 1, 2010
3rd Annual Dallas Undy 5000 5K Run Sets Attendance Record
Run Raises Much Needed Funds and Brings Greater Awareness to Colon Cancer
Dallas, TX (November 1, 2010) – The Colon Cancer Alliance’s 3rd Annual Dallas Undy 5000 5K run was held on Saturday, October 30 at 8:30 AM at Winfrey Point at White Rock Lake in Dallas, TX. 750 residents participated in the event to help bring greater awareness to colon cancer, the 2nd leading cause of cancer death in the United States.
“The third annual Dallas Undy 5000 set an attendance record this year,” said Andrew Spiegel, CEO of the Colon Cancer Alliance (CCA). “Dallas residents have been phenomenal in helping to bring greater awareness to colon cancer. This year, $80,000 was raised to support and build the CCA’s national and local patient support and innovative public awareness programs. In addition, a generous portion of the proceeds will be dispersed locally to fund treatment services for those diagnosed with colon cancer.”
The Undy 5000 series, created by the CCA and held in cities across the nation, is designed to promote awareness and education about colon cancer. The event stresses the importance of timely colon cancer screening, and provides valuable information for those already affected by the disease. The American Cancer Society estimates that 142,000 new cases will be diagnosed this year. Through recommended screenings, this cancer can be caught early when treatment is most effective — or even prevented altogether when pre-cancerous polyps are detected and removed.
Local sponsors of the event included Texas Colon & Rectal Specialists and ALON USA. National sponsors of this event included Amgen Oncology, ASCRS (American Society of Colon and Rectal Surgeons), Bristol Myers Squibb, Ethicon Endo-Surgery, Genentech, MITA (Medical Imaging and Technology Alliance) and Salix Pharmaceuticals.
More information about the Undy 5000 is available online at www.undy5000.org.
# # #
The Colon Cancer Alliance (CCA) is a national patient advocacy organization dedicated to ending the suffering caused by colorectal cancer. In order to increase rates of screening and survivorship, the CCA provides patient support, public education, supports research and conducts advocacy work across America.